This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 19 Dec 2013  |  Global  |  Market Research

    Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market

    Innovative Drugs to Launch in the Next 3 Years, Impacting the Insulin and Non-insulin Markets

    Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...

    $2,450.00
  2. 17 Dec 2013  |  Global  |  Market Research

    World LED Lighting Markets (2013 Update)

    Government Initiatives and Declining Prices are Driving the High Growth

    The key challenges that the LED lighting market face are the prevalence of alternate technologies and high initial investment. Raising awareness amidst residential end users, financing projects, and leasing and maintenance of lighting solutions in the professional lighting market can tackle these challenges and provide untapped opportunities. End u...

    $3,950.00
  3. 11 Dec 2013  |  Global  |  Market Research

    Analysis of the US Retinal Therapeutics Market

    Improvements in Administration and Efficacy Drive Growth

    The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...

    $4,950.00
  4. 31 Oct 2013  |  Global  |  Market Research

    Chinas 2013 Life Sciences Industry Outlook and Regulatory Review

    Government Investments Could Make China the Third-largest Pharmaceutical Market in the World

    China is predicted to become the third-largest pharmaceutical market in the world by the end of 2013 due to the governments considerable investment in the healthcare industry and the populations unmet healthcare needs. The life sciences industry is broad and involves a wide range of disciplines. This research service focuses on the trends and mar...

    $4,950.00
  5. 15 Oct 2013  |  Global  |  Market Research

    A Product and Pipeline Analysis of the Latin American HIV, Chagas, Dengue, and Influenza H1N1 Therapeutics Markets

    High Incidence of Infectious Diseases Persists, While Treatment Options Remain Scarce

    Latin America presents many opportunities for the infectious diseases market. This market insight offers an overview of the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well...

    $3,950.00
  6. 08 Oct 2013  |  Global  |  Market Research

    Global Next Generation Sequencing Informatics Market

    Informatics Vendors Flock to Growth in Sequencing Adoption

    More than 100 companies participate in the global next generation sequencing (NGS) informatics market. This research service evaluates the market from 2012 to 2018. The research covers key market drivers and restraints, analysis of the changing competitive landscape, revenue forecasts, and the important trends that affect market growth. Also includ...

    $4,950.00
  7. 30 Apr 2013  |  Global  |  Market Research

    Outsourcing to CMOs in Emerging EconomiesBoon or Bane?

    Analyzing the Prospects of CMOs in Emerging Markets

    This issue of Vital Signs discusses the acquisition of Cellular Research by Beckton Dickinson, collabaration of Illumina and Asuragen on companion diagnostics, a landmark NIH study on blood pressure management, and drug price hikes.

    $1,500.00
  8. 23 Apr 2013  |  Global  |  Market Research

    Healthcare Landscape, Outlook, and Growth Opportunities in India

    The healthcare market in India is in a growth stage and the growth rate is as high as any other fast-growing markets in the country. Moreover, the healthcare market is expected to drive the economy in the coming years. The main factors driving the growth are rising population, change in demographics, rise in disposable income, change in disease pro...

    $4,950.00
  9. 09 Apr 2013  |  Global  |  Market Research

    The Future of Biopharmaceutical Contract Manufacturing in Europe - What Underpins the Success of CMOs?

    European Biopharmaceutical Contract Manufacturing Market

    This issue of Vital Signs, released in July 2015, discusses Affmetrix's acquisition of Eureka Genomics, OPKO Health's acquisition of Bio-Reference Laboratories, CVS Health's acquisition of Target's in-store pharmacies and clinics, and Thermo Fisher Scientific's acquisition of Alfa Aesar.

    $1,500.00
  10. 26 Mar 2013  |  Global  |  Market Research

    Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS

    Persistent Unmet Need Fuels Antiviral Drug Development for Bloodborne Pathogens

    This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and H...

    $1,500.00